Hypoxia or hypoxia mimetic has been shown to induce differentiation together with the accumulation of hypoxiainducible factor-1a (HIF-1a) protein of myeloid leukemic cells and normal hematopoietic progenitors. To provide direct evidence for the role of HIF-1a in acute myeloid leukemia (AML) cell differentiation and its mechanisms, we generated myeloid leukemic U937T transformants, in which HIF-1a was tightly induced by tetracycline withdrawal. The results showed that the conditional HIF-1a induction triggered granulocytic differentiation of these transformants, while the suppression of HIF-1a expression by specific short hairpin RNAs (shRNAs) effectively inhibited hypoxia-induced differentiation of U937 cells, as evidenced by morphology, maturation-related antigens as well as expressions of myeloid differentiation signatures and hematopoietic cells-specific cytokine receptors. The specific shRNAs-inhibited expression of HIF-1b, an essential partner for transcription activity of HIF-1, failed, while the inhibition of hematopoietic differentiation-critical CCAAT/enhancer-binding protein-a (C/EBPa) significantly eliminated HIF-1a-mediated myeloid leukemic cell differentiation. Collectively, this work provided several lines of direct evidence for the role of HIF-1a protein through its nontranscriptional activity in myeloid cell differentiation, in which C/EBPa elicits a role as an effector downstream to HIF-1a. These discoveries would shed new insights for understanding mechanisms underlying leukemogenesis and designing the new therapeutic strategy for differentiation induction of AML.
Introduction
The hematopoietic stem cells undergo a process of commitment to multipotential progenitors, which in turn give rise to mature blood cells. A small group of transcription factors, such as CCAAT/enhancer-binding protein a (C/EBPa), Runx1 (originally named acute myeloid leukemia 1 (AML1)) and PU.1, play crucial roles in controlling normal hematopoiesis (Friedman, 2002) . The structural and functional abnormalities of these factors also contribute to the pathogenesis of AML, in which the normal differentiation program is blocked (Peterson and Zhang, 2004; Rosenbauer et al., 2005) .
Hypoxia-inducible factor 1 (HIF-1), a transcription factor heterodimerized by oxygen-sensitive HIF-1a with constitutively expressed HIF-1b (also named aryl hydrocarbon receptor nuclear transporter (ARNT)), is critical for adaptive response on cellular hypoxia. As widely reviewed by Semenza (2000) , two highly conserved prolines (proline 402/564) of HIF-1a protein are hydroxylated by HIF-1a-specific prolyl hydroxylases. The von Hippel-Lindau tumor suppressor, a part of an E3 ubiquitin ligase, interacts with the hydroxylated HIF-1a protein and targets HIF-1a to the proteasome for its degradation. Depletion of oxygen (hypoxia) or treatment of cobalt chloride (CoCl 2 )/desferrioxamine (DFO) results in stabilization of HIF-1a protein.
Consequently, the stabilized HIF-1a protein is translocated to the nucleus, followed by heterodimerization with HIF-1b. HIF-1 heterodimer binds to the hypoxiaresponsive element in the cis-acting sequences and regulates an impressive array of target genes to overcome hypoxic stress.
Our recent works found that 2% O 2 and nontoxic concentrations of CoCl 2 /DFO induce myeloid leukemic cells to undergo differentiation (Huang et al., 2003; Jiang et al., 2005) . Intermittent hypoxia also significantly prolongs the survival of the transplanted acute promyelocytic leukemia (APL) mice with inhibition of infiltration and differentiation induction of leukemic cells . Additionally, the differentiation of normal human CD34 þ hematopoietic progenitor cells is also accelerated under the hypoxia condition, which is inhibited by HIF-1a-interacting TEL-ARNT fusion protein, which was generated by a chromosomal translocation (1;12)(q21;p13) in human AML (SalomonNguyen et al., 2000; Nguyen-Khac et al., 2006) . All these data suggest the role of HIF-1a in AML cell differentiation (Chen et al., 2006) . To date, however, no direct evidence is provided for this notion. In this work, we provided the first demonstration that inducible expression of HIF-1a protein directly induces AML cell differentiation, while the suppression of HIF-1a and C/EBPa, but not HIF-1b expression by short hairpin RNA (shRNA), eliminates HIF-1a-mediated myeloid leukemic cell differentiation.
Results

HIF-1a induction triggers differentiation with growth arrest of myeloid leukemic cells
To investigate the potential direct role of HIF-1a in the differentiation of myeloid leukemic cells, we generated inducible HIF-1a-expressing U937T cell lines by tetracycline-off system (see Supplementary Materials for details), including one pool (U937T pool ) and one clone (U937T clone ). An U937T cell with transfection of empty vector (U937T empty ) was used as a control. HIF-1a protein could be significantly induced in U937T pool and U937T clone rather than U937T empty cells in the similar dynamics to mRNA induction after tetracycline removal, although cells were under normal oxygen tension ( Figure 1a and Supplementary Figure S1 ). The growth curves showed that the proliferation was substantially slowed down in U937T clone and U937T pool cells compared with in U937T empty cells, which were initiated 4 days after tetracycline removal (induction of HIF-1a expression), and continued (Figure 1b ). According to analysis of the flow cytometry-based DNA content of propidium iodide-stained nuclei, furthermore, the percentage of cells in G 0 /G 1 phase dramatically increased together with the reduced cells in S phase, which began to appear at day 3 after tetracycline removal and became more significant later (Figure 1c) , indicating the blockage of the G 1 to S phase transition. At all time points tested, by the way, cell viability kept over 95% without the appearance of sub-G 1 cells, proposing that HIF-1a expression failed to induce cell death.
Next, we determined whether HIF-1a induction directly triggers myeloid leukemic cells to undergo differentiation. Toward this end, U937 or its derived transformants as well as APL cell line NB4 with 10 À6 M all-trans retinoic acid (ATRA) or 10 À7 M vitamin D 3 treatment for 3 days were used as positive controls. As reported previously (James et al., 1997) , ATRA induced granulocytic differentiation in NB4 and U937 cells, while vitamin D 3 triggered U937 cells to monocytic differentiation (Figure 2 ). When HIF-1a had been induced for 4-5 days, as expected, U937T pool and U937T clone exhibited differentiation-related morphological changes such as lessened cell size, condensed chromatin and decreased nuclei/cytoplasm ratio with smaller and distorted nuclei (Figure 2a ). These morphological alterations appeared more obvious than 3 days' treatment of ATRA at 10 À6 M ( Figure 2a ) and vitamin D 3 at 10 À7 M (data not shown). Like 0 U937T empty U937T clone U 9 3 7 T e m p ty U 9 3 7 T c lo n e U 9 3 7 T e m p ty U 9 3 7 T c lo n e U 9 3 7 T e m p ty U 9 3 7 T c lo n e U 9 3 7 T e m p ty U 9 3 7 T c lo n e U 9 3 7 T e m p ty U 9 3 7 T c lo n e U 9 3 7 T e m p ty U 9 3 7 T c lo n e HIF-1a and leukemic cell differentiation L-P Song et al ATRA-treated cells, furthermore, HIF-1a induction remarkably increased CD11b and CD11c but not CD14 expression, an indication for granulocytic differentiation ( Figure 2b ). Nitroblue tetrazolium (NBT) reduction also increased slightly but statistically significantly in U937T pool and U937T clone cell lines upon HIF-1a induction (Figure 2c and data not shown). By the way, ATRA or vitamin D 3 treatment upregulated expressions of neutrophil cytosolic factor-1 (NCF1), interleukin-1 receptor antagonist (IL1RN), orosomucoid 1 (ORM1) and secreted phosphoprotein 1 (SPP1) in NB4 cells, four myeloid cell differentiation signatures recently identified (Stegmaier et al., 2004) , while ATRA only increased NCF1 expression and vitamin D 3 raised expressions of other three markers except for SPP1 in U937 cells (Figure 2d ). In U937T pool and U937T clone cell lines, HIF-1a induction significantly increased NCF1, SPP1 and IL1RN expression. All these morphological alterations, increased CD11/NBT reduction, and expressions of differentiation signatures could not be seen in U937T empty cell line in the presence and absence of tetracycline. By the way, ATRA appeared to increase HIF-1a protein in U937T clone cells in the presence of tetracycline ( Figure 2e ). All these data indicate that the differentiation-inducing effect is due solely to the expression of HIF-1a protein in U937T pool and U937T
clone cell lines.
Suppression of HIF-1a expression by shRNAs remarkably blocks hypoxia-induced differentiation of myeloid cells Consistent with our previous reports (Huang et al., 2003) , 50 mM of CoCl 2 and 2% O 2 , which induced HIF1a protein accumulation (Figure 3a ), could trigger U937 cells to undergo granulocytic differentiation, as evidenced by morphology (Supplementary Figure S1 ) and CD11 expression ( Figure 3b ). To validate further the role of HIF-1a protein in the hypoxia-induced differentiation, three pairs of shRNAs specifically against HIF-1a mRNA were respectively transfected into the parental U937 cells with negative control shRNA as a control. After selected by G418, two pairs of shRNAs (shR-a14 and shR-a16) were more effective. As can be seen in Figure 3a , shR-a16 and especially shR-a14 but not negative control significantly eliminated HIF-1a protein induced by 2% O 2 and especially by 50 mM CoCl 2 . Of note, these shRNAs failed to damage HIF-1b expression, indicating their specificity against HIF-1a.
Compared with negative control, more intriguingly, the shR-a16 and especially shR-a14 interferences significantly antagonized CoCl 2 and 2% O 2 -induced differentiation of U937 cells ( Figure 3b and Supplementary Figure S2 ), indicating the direct contribution of HIF-1a to hypoxia and CoCl 2 -induced differentiation of myeloid leukemic cells. HIF-1a and leukemic cell differentiation L-P Song et al Suppression of HIF-1b expression by shRNAs fails to impact hypoxia-induced myeloid cell differentiation As described above, HIF-1a protein must heterodimerize with HIF-1b for its transcription activity. To figure out whether HIF-1a-mediated differentiation involves its transcriptional activity, five pairs of shRNAs specifically against HIF-1b mRNA (shR-b) were transfected into the parental U937 and U937T clone cell lines with negative control shRNA as a control. After selected by G418, two pairs of shR-bs (shR-b2 and especially shR-b5) stably eliminated HIF-1b protein in U937 cells (Figure 4a ), especially in U937T clone cell line (Figures 4b  and c) . The suppression of HIF-1b expression by shR-b5 significantly inhibited 2% O 2 treatment-induced expressions of Glut-1 and vascular endothelial growth factor, two commonly used HIF-1 target genes, in both U937 and U937T clone cells. Such inhibitions could also be seen in these two cells interfered by shR-b2 with lower interfering effect than shR-b5, although statistical significance was absent compared with negative control transfection (Supplementary Figure S3) . These data suggest that the reduced HIF-1b expression by shRNAs damaged transcriptional activity of HIF-1. In the presence of the suppression of HIF-1b expression, however, 50 mM CoCl 2 or 2% O 2 treatment for 6 days still induced differentiation of parental U937 cells to the same degree as that in negative control transfection (Figure 4a) . Similarly, the silence of HIF-1b expression neither damaged CoCl 2 -induced differentiation of U937T clone cell line in the presence of tetracycline (Figure 4b ) nor impacted HIF-1a induction-triggered differentiation of this cell line after tetracycline withdrawal (Figure 4c ). Collectively, these results indicate that HIF-1b is not necessary for hypoxia/HIF-1a-mediated myeloid cell differentiation. (Figure 5a) . Moreover, the time-course analysis found that M-CSFR began to increase at the third day after tetracycline withdrawal and became more significant later, which was in accordance with the differentiation induction (Figure 2) . The similar upregulation could also be seen in 2% O 2 -treated parental U937 (Figure 5b ). The knockdown of HIF-1a expression by shR-a14 also partially inhibited the expression of all these three receptors induced by 2% O 2 , comparing with the negative control cells (Figure 5b ). Of note, the interference of shR-a16 did not cause the significant inhibition of G-CSFR and GM-CSFR expression, possibly due to its lower interfering action (Figure 3a) . Furthermore, HIF-1b interfering by shR-b2 or shR-b5 shRNA did not impinge on expressions of these receptors during HIF-1a induction-mediated differentiation in U937T clone cells (Figure 5c ), which was consistent to its inability to affect HIF-1a induction-triggered differentiation (Figure 4c) .
Role of C/EBPa in HIF-1a-mediated myeloid cell differentiation C/EBPa, a critical transcription factor for myeloid cell differentiation (Friedman, 2002; Mueller and Pabst, 2006) , has been shown to be required to activate growth factor receptor genes M-CSFR, G-CSFR and GM-CSFR. On the other hand, the physical and functional interaction between HIF-1a and C/EBPa proteins was reported previously (Jiang et al., 2005) . Thus, we assumed that HIF-1a induction-triggered myeloid cell differentiation is related to C/EBPa protein. Herein, we showed that C/EBPa protein decreased gradually from the third day after tetracycline removal in both U937T
clone and U937T pool cell lines, but HIF-1a β-actin Figure 3 The suppression of hypoxia-inducible factor-1a (HIF-1a) expression by shRNA inhibits 2% O 2 and CoCl 2 -induced differentiation of U937 cell line. The parental U937 cell lines were stably transfected by shR-a14, shR-a16 or negative control. Then, these cell lines were treated with 2% O 2 (H) or 50 mM CoCl 2 (Co) for 2 days (a) or 6 days (b). HIF-1a/HIF-1b protein levels (a) and CD11b þ /CD11c þ cells (%) (b) were measured. *P-value compared with the negative control-transfected cell line.
HIF-1a and leukemic cell differentiation L-P Song et al induction failed to impact protein levels of AML1 and PU.1 (Figure 6a ), other two hematopoiesis-critical transcription factors (Friedman, 2002) . Later, we stably introduced five pairs of shRNAs to specifically interfere C/EBPa expression (shR-C) in U937T clone cell line. As depicted in Figures 6b and c , two shRNAs (shR-C1 and especially shR-C2) more effectively reduced the C/EBPa protein with no influence on HIF-1a protein. More intriguingly, the reduced C/EBPa expression by shR-C1 and shR-C2 significantly suppressed G-SCFR and M-CSFR upregulation by HIF-1a induction in U937T clone cell line (Figure 5d ). In parallel, shR-C1 and Figure 4 The suppression of hypoxia-inducible factor-1b (HIF-1b) expression by shRNA does not impact hypoxia/HIF-1a inductiontriggered differentiation of U937 and U937T cell lines. The parental U937 (a) and U937T clone cell lines (b and c) were stably transfected by shR-b2, shR-b5 or negative control. Then, these cell lines were treated respectively with 2% O 2 (H) and 50 mM CoCl 2 (Co) for 2 days (a), 50 mM CoCl 2 (b) or grown in tetracycline-free medium for the various days as indicated (c), and then HIF-1a/HIF-1b protein levels were measured with b-actin as loading controls. For the measurement of CD11 þ cells, all cell lines were treated with the corresponding insults for 6 days (a and b) or grown in tetracycline-free medium for 5 days (c). HIF-1a and leukemic cell differentiation L-P Song et al shR-C2 interferences also inhibited HIF-1a induction-triggered or CoCl 2 -induced differentiation in the U937T clone cell line in the absence or presence of tetracycline, as determined by CD11 expression (Figures 6b and c) .
Discussion
Here we generated myeloid leukemic U937T transformants with inducible HIF-1a expression. Such a system presented the advantage of not having been directly selected for the expression of the targeted gene during its establishment. As such, it had not been preselected with the possible particular features before the induced expression of the targeted protein, as described previously (Boer et al., 1998; Huang et al., 2006) . In U937T pool and U937T clone cell lines, HIF-1a expression was tightly regulated and induced upon tetracycline withdrawal at both mRNA and protein levels, although a little leakage of expression could be seen. Of note, HIF-1a mRNA and protein levels did not keep durative increase after tetracycline removal, which was in line with the fact that HIF-1a protein during prolonged hypoxia negatively regulates HIF-1a expression through an increase in a natural antisense HIF-1a, which destabilizes HIF-1a mRNA (Thrash-Bingham and Tartof, 1999) .
Using these U937T transformants, we examined possible effects of HIF-1a induction on the growth arrest and differentiation of leukemic U937T cells. The results showed that HIF-1a induction could inhibit cell growth with the blockage of the G 1 to S phase transition. Upon HIF-1a induction, of great importance, U937T pool and U937T clone but not U937T empty cell lines presented the significant granulocytic differentiation-related phenotypes, such as more matured morphologic features, increased percentage of CD11 þ / CD14 À cells and the upregulated expression of three myeloid cell differentiation signatures (NCF1, SPP1 and IL1RN). As reported (Scott et al., 1992; Tenen et al., 1997; Barreda et al., 2004) , granulocytic maturation of hematopoietic cells in most cases were accompanied with the increased G-CSFR, GM-CSFR and M-CSFR expressions, while the C/EBPa expression was downregulated. The similar alterations could also appear in U937T pool and U937T clone cell lines upon HIF-1a induction, further supporting the differentiation-inducing effect of HIF-1a induction.
Considering the possible artifact in overexpressing cell context, we also stably transduced shRNAs specifically against HIF-1a expression into U937 cells. The results showed that the suppression of HIF-1a expression could effectively inhibit 2% O 2 and CoCl 2 -induced differentiation of U937 cells, further proposing the role of HIF-1a in hypoxia-induced differentiation. It should be pointed out that the differentiation was not completely blocked by these two shRNAs. We suggested that this was mainly due to partial inhibition of HIF-1a expression by shRNAs tested here, but the possibility could not be excluded that some other hypoxia-responsive elements also contribute to hypoxia-induced differentiation. If this is true, HIF-2a (the second member of the HIF family) should be considered as one of the candidates, because it was reported to be required for normal hematopoiesis in mice (Scortegagna et al., 2003) .
HIF-1a/HIF-1b heterodimer acts as a transcription factor through binding to the hypoxia-responsive element in the cis-acting sequences (Semenza, 2000) . More recently, nontranscriptional activity of HIF-1a protein was also proposed (Koshiji et al., 2004) . To understand whether transcription action of HIF-1a protein is required for its differentiation induction, the expression of HIF-1b was suppressed by shRNAs with reduced expression of HIF-1-targeted genes. However, such a silence failed to affect hypoxia-induced differentiation of U937 and U937T
clone cell lines, indicating that HIF-1b is unnecessary for HIF-1a-mediated differentiation. In other words, nontranscriptional activity of HIF-1a protein contributes to its differentiation-inducing effect.
As described above, C/EBPa is required to activate myeloid-specific genes, including growth factor receptor genes such as M-CSFR, G-CSFR and GM-CSFR. Recently, Suh et al. (2006) proposed that this transcription factor determines hematopoietic cell fate in multipotential progenitor cells by inducing myeloid differentiation and inhibiting erythroid differentiation. Although we could not find that HIF-1a induction significantly increased C/EBPa expression in the early phase of differentiation induction as seen in ATRAtreated AML cells (Hong et al., 2004) , previously we did show that HIF-1a interacts physically with and increases the transcriptional activity of C/EBPa (Jiang et al., 2005) . It remains to be investigated whether HIF-1a induction increases C/EBPa activity in the U937T pool and U937T
clone cell lines. Further, our previous works showed that AML1-ETO induction in the ecdysoneinducible system from parental U937 cells inhibited DFO-induced cell differentiation, which was parallel to inhibition of C/EBPa (Jiang et al., 2005) . However, the suppression of C/EBPa expression by its specific shRNAs could significantly suppress G-SCFR and M-CSFR upregulation and HIF-1a induction or CoCl 2 -induced differentiation in the U937T clone cell line. All these results strongly propose the role of C/EBPa in HIF-1a-mediated differentiation of myeloid leukemic cells.
Taken together, this work provided several lines of direct in vitro evidence for the role of HIF-1a protein through its nontranscriptional activity in myeloid leukemic cell differentiation, in which C/EBPa elicits a role as an effector downstream to HIF-1a protein. These discoveries would shed new insights for understanding mechanisms underlying leukemogenesis and designing the new therapeutics for differentiation induction of AML.
Materials and methods
Cell culture and establishment of U937T transformants with inducible HIF-1a expression
The human promonocytic leukemic cell line U937 and APL cell line NB4 were cultured in RPMI 1640 medium (Sigma-Aldrich, St Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS, HyClone, Logan, UT, USA). U937T cells, kindly provided by Daniel G Tenen of Harvard Medical School, were cultured in RPMI-1640 medium supplemented with 10% FBS, 1 mg/ml of tetracycline (Sigma-Aldrich) and 0.5 mg/ml of puromycin (Sigma-Aldrich). U937T stable transformants with inducible HIF-1a expression were generated according to methods described in Supplementary Materials. All cells were maintained in an incubator at 371C with 5% CO 2 . For experiments, cells originally seeded at 2 Â 10 5 cells/ml were incubated with ATRA, CoCl 2 (Sigma-Aldrich) or vitamin D 3 (Calbiochem, La Jolla, CA, USA) or cultured in a specially designed hypoxia incubator (Thermo Electron, Forma, MA, USA) and 2% O 2 was generated by flushing a 93% N 2 /5% CO 2 mixture into the incubator. Cell viability was determined by the trypan-blue exclusion assay.
shRNA design and transfection Pairs of complementary oligonucleotides against HIF-1a, HIF1b and C/EBPa were synthesized by Invitrogen (Shanghai, China), annealed and ligated into pSilencer 3.1-H1-neo vector (Ambion, Austin, TX, USA). Target sequences are provided in Supplementary Materials. These shRNA vectors and negative control pSilencer neo vector (Ambion) were transfected respectively using the Bio-Rad Gene-Pulser II with the square-wave electroporation of two pulses, 0.18 kV, 25 ms, 1 Hz for U937 and two pulses, 0.20 kV, 25 ms, 1 Hz for U937T clone cell line. After 48 h, 300 and 1000 mg G418/ml (Calbiochem) respectively were added to the medium and the stable transformants were selected by testing targeted proteins.
Cell cycle and differentiation assay Cell morphological features were examined by microscope after Wright's staining of cells that were collected onto slides by cytospin (Shandon, Runcorn, UK). Cell surface differentiation antigens CD11b, CD11c and CD14 were measured using fluorescein isothyiocyanate-or phycoerythrin-labeled antibodies with Isotype Controls (Beckman-Coulter, Miami, FL, USA) via flow cytometry (Beckman-Coulter). The distribution of nuclear DNA contents was analysed by flow cytometry (Beckman-Coulter) and NBT reduction was performed as previously described (Chen et al., 1997) . In addition, mRNA levels of four leukemic cell differentiation signatures, NCF1, IL1RN, ORM1 and SPP1, were measured by semiquantitative RT-PCR as described previously .
Quantitative RT-PCR Total cellular RNA was extracted by TRIzol reagent (Invitrogen, Carlsbad, CA, USA), followed by treatment with RNasefree DNase (Promega, Madison, WI, USA). RT was performed by using the cDNA synthesis kit according to the manufacturer's instruction (Applied Biosystem, Forster City, CA, USA). Real-time PCR was performed and data were analysed according to our previous report (Zhao et al., 2004) . The related specific primers for b-actin, HIF-1a, HIF-1b, M-CSFR, G-CSFR and GM-CSFR are described in Supplementary Materials.
Nuclear/cytoplasmic fractionation and western blot Cell lysates or nuclei/cytoplasm, which were fractionated as described in Supplementary Materials, were equally loaded to 10% sodium dodecyl sulfate-polyacrylamide gel, electrophoresed and transferred to ECL-nitrocellulose (Amersham, Buckinghamshire, UK). The membranes were stained with 0.2% Ponceau S red to ensure equal protein loading. After blocking with 5% nonfat milk in Tris-buffered saline, the membranes were incubated with the monoclonal antibodies against HIF-1a and HIF-1b (BD Transduction, San Jose, CA, USA), polyclonal antibodies against C/EBPa, AML1 and PU.1 (Santa Cruz, CA, USA), followed by horseradish peroxidase (HRP)-linked secondary antibody (Cell Signaling, Beverly, MA, USA) for 1 h at room temperature. Detection was performed by chemiluminescence phototope-HRP kit according to the manufacturer's instruction (Cell Signaling). As necessary, blots were stripped and reprobed with anti-bactin (Merck, Darmstadt, Germany) or lamin B (Santa Cruz) antibody as internal controls. All experiments were repeated for three times with the similar results.
Statistical analysis
All experiments were repeated for at least three times, and the same results were obtained. All values represent the means with bar as standard deviation of triplicates in an independent experiment. The t-test was used to compare the difference between two groups. A value of Po0.05 was considered to be statistically significant.
